6 results match your criteria: "130 University Campus NW[Affiliation]"
Therap Adv Gastroenterol
February 2024
Division of Gastroenterology, University of Alberta, Edmonton, AB, Canada.
Background: Despite recent emerging literature involving the utility of endoscopic balloon dilation (EBD) of strictures balloon-assisted endoscopy (BAE), specifically regarding the management of Crohn's disease (CD), the optimal clinical approach with balloon systems has been largely neglected in academic literature.
Objectives: This study assesses the intra-procedural success and safety of EBD BAE for small bowel CD strictures while detailing our clinical approach and technique. Secondarily, we compare the single-balloon endoscope (SBE) and double-balloon endoscope (DBE) systems for EBD-related outcomes.
Therap Adv Gastroenterol
September 2022
Division of Gastroenterology, Department of Medicine, University of Alberta, 130 University Campus NW, Edmonton, AB T6G 2X8, Canada.
Background: Psychological stress negatively impacts inflammatory bowel disease (IBD) outcomes. Patients have prioritized access to online interventions; yet, the data on these have been limited by mixed in-person/online interventions, low adherence, and non-randomized controlled trial (RCT) design.
Objectives: We assessed the efficacy of and adherence to a 12-week online multicomponent stress reduction intervention in IBD.
Dig Dis Sci
June 2022
Division of Gastroenterology, Department of Medicine, McGill University, Montreal, Canada.
Background: In this systematic review, our objective was to assess inflammatory bowel disease (IBD) patient preferences and perspectives relating to their disease diagnosis, treatment, knowledge needs and telemedicine.
Methods: This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Four databases and conference proceedings were searched between January 1, 1980, and May 1, 2020.
Dig Dis Sci
November 2021
Division of Gastroenterology, University of Alberta, 130 University Campus NW, Edmonton, AB, T6G 2X8, Canada.
Background And Aims: While there is recent literature to support the discontinuation of 5-aminosalicylate (5-ASA) upon the initiation of biologics, continuing 5-ASA after treatment failure is relatively common. We aimed to assess the impact of concomitant 5-ASA therapy on clinical outcomes in ulcerative colitis (UC) patients escalated to infliximab.
Methods: This is a retrospective chart review of patients with moderate-to-severe UC started on infliximab between January 2012 and December 2017 at the University of Alberta.
Dig Dis Sci
May 2021
Division of Gastroenterology, Mount Sinai Hospital, Sinai Health System, University of Toronto, Suite 441-600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Background: The role of fecal calprotectin in predicting pregnancy-related outcomes in inflammatory bowel disease (IBD) remains unknown.
Aim: To determine whether increased fecal calprotectin during pregnancy is associated with adverse pregnancy outcomes in IBD.
Methods: This is a multicenter cohort study of women with IBD who underwent fecal calprotectin monitoring during pregnancy.
J Crit Care
October 2014
Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, 3C1.12 Walter C Mackenzie Center, 8440-112 ST NW, Edmonton, Alberta, T6G-2B7, Canada. Electronic address:
Purpose: Intensive care unit (ICU) readmission negatively impacts patients' outcomes. We aimed to characterize and determine risk factors for ICU readmission within the initial hospital stay after liver transplant (LT).
Materials And Methods: The reference cohort included 369 LT recipients from a Canadian center between 2005 and 2012.